Physician profile
Scott Reed Lambert
NPI 1093748766
$19,984.65
in general payments reported to CMS, 2019-2025
7 companies · $3,273 in 2025
The $3,273 reported for 2025 was more than what 95% of Pediatric Ophthalmology and Strabismus Specialist providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,752 · 2020: $938 · 2021: $1,668 · 2022: $3,212 · 2023: $4,330 · 2024: $1,813 · 2025: $3,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,020 · Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,020.00 |
| Food and Beverage | $395.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19,350.00 | 2019-2025 | |
| Genentech USA, INC. | $257.41 | 2022-2023 | Vabysmo |
| Lumenis Be INC | $252.05 | 2023 | Optilight |
| Novartis Pharmaceuticals Corporation | $102.11 | 2019 | |
| Glaukos Corporation | $23.08 | 2025 | Istent Infinite, Idosetr |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.